24 reports

AND BIELORY, L. (2012) ' ALLERGIC CONJUNCTIVITIS AND DRY EYE SYNDROME', ANNALS OF ALLERGY, ASTHMA & IMMUNOLOGY, ##(##), PP. ##-##.

  • Ophthalmic Solution
  • Forecast
  • Allergan plc
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

In May 2017, the Danish Asthma and Allergy association launched a national campaign called " Snot or Not".

  • Ophthalmic Solution
  • OTC
  • Denmark
  • Demand
  • Orkla Group

A large number of people suffer from respiratory problems such as hay fever and asthma, and the poor air quality worsens their health PROSPECTS Passport ## conditions.

  • Ophthalmic Solution
  • OTC
  • Vitamin
  • China
  • Demand

The list of vitamins and minerals that can be used is regulated by ordinance EG ##, ##/ 2009.

  • Ophthalmic Solution
  • Sweden
  • Forecast
  • GlaxoSmithKline plc
  • Orkla Group

CURRENT ALLERGY AND ASTHMA REPORTS; ##: ##-##.

  • Ophthalmic Solution
  • Market Size
  • Allergan plc
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • ALLERGIC CONJUNCTIVITIS - PIPELINE BY GRIFFIN DISCOVERIES BV, H1 2018
  • ZAFIRLUKAST - DRUG PROFILE

It is in Phase I stage for atopic dermatitis, psoriasis, and asthma.

  • Ophthalmic Solution
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.

Current Allergy and Asthma Reports; ##: ##-##.

  • Ophthalmic Solution
  • Allergan plc
  • Mitotech S.A.
  • RegeneRx Biopharmaceuticals, Inc.
  • Santen Pharmaceutical Co., Ltd.
  • ALLERGIC CONJUNCTIVITIS - PIPELINE BY GRIFFIN DISCOVERIES BV, H2 2017
  • Allergic Conjunctivitis - Companies Involved in Therapeutics Development

The company offers pipeline formulations for atopic dermatitis, allergic conjunctivitis, allergic asthma, and allergic rhinitis.

  • Ophthalmic Solution
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • Clinical Trial profile. 43 Trial Title
  • Clinical Trial Profile Snapshots

Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Allergic Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview of Allergic Rhino-Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical...

  • Healthcare
  • Ophthalmic Solution
  • OTC
  • World
  • Product Initiative
  • Clinical Trial profile. 109 Trial Title
  • Clinical Trial profile. 3 Trial Title

Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Rhino-Conjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview of Rhino-Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Rhino-Conjunctivitis....

  • Allergy Drug
  • Ophthalmic Solution
  • OTC
  • World
  • Product Initiative
  • Clinical Trial profile. 493
  • Clinical Trial profile. 438

Conjunctivitis Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Conjunctivitis Global Clinical Trials Review, H1, 2017" provides an overview of Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Conjunctivitis. Report includes...

  • Clinical Trial
  • Ophthalmic Solution
  • Pharmaceutical
  • Therapy
  • World
  • Clinical Trial profile. 121 Trial Title
  • Clinical Trial profile. 299 Trial Title

Conjunctivitis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Conjunctivitis Global Clinical Trials Review, H2, 2016" provides an overview of Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Conjunctivitis. Report includes...

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • OTC
  • World
  • Patent

The global topical drug delivery market is poised to reach USD 125.88 billion by 2021 from USD 92.40 billion in 2016, growing at a CAGR of 6.4% from 2016 to 2021. Major factors driving the growth of this market are the high incidence of burn injuries, rising geriatric population, and increasing incidence of diabetes. The topical drug...

  • Hospital
  • Ophthalmic Solution
  • North America
  • United States
  • Market Size
  • Chapter 5: Ophthalmic Anti-Allergy / Inflammatory / Infective Market 2014 - 2024

ALLERGIC CONJUNCTIVITIS IS COMMON IN PEOPLE WHO HAVE OTHER ALLERGIC DISEASE SUCH AS HAY FEVER, ASTHMA AND ECZEMA.

  • Ophthalmic Solution
  • Alcon, Inc.
  • Allergan plc
  • Merck & Co., Inc.
  • Novartis AG

Its OTC products find application in the treatment of asthma, influenza, allergy, allergic rhinitis and chronic obstructive pulmonary disease, among others.

  • Eye Disease
  • Ophthalmic Solution
  • United States
  • M&A
  • NicOx S.A.

And finally, Nicox will make a one-time cash payment of & euro##, ## to VISUfarma.

  • Medical Device
  • Ophthalmic Solution
  • United States
  • Company
  • NicOx S.A.
  • Clinical Trial profile. 207 Trial Title
  • Clinical Trial profile. 195 Trial Title

Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2016 Summary GlobalData's clinical trial report, “Rhino-Conjunctivitis Global Clinical Trials Review, H1, 2016" provides an overview of Rhino-Conjunctivitis clinical trials scenario. This report provides top line data relating to the clinical trials on Rhino-Conjunctivitis....

  • Ophthalmic Solution
  • OTC
  • Pharmaceutical
  • World
  • Product Initiative
  • Official Title
  • Clinical Trial profile. 161 Trial Title

The prominent features of this report are - ##.

  • Ophthalmic Solution
  • OTC
  • Respiratory Treatment
  • World
  • Product Initiative

The pivotal Phase ## LIBERTY ASTHMA QUEST study of dupilumab for the treatment of asthma completed enrollment during the third quarter of 2016.

  • Healthcare
  • Ophthalmic Solution
  • North America
  • United States
  • Alcon, Inc.

Asthma - Drug Profile ## Product Description ## Mechanism of Action ## R& D Progress ## Allergen for Birch Pollen Induced Allergic Rhinitis and Rhinoconjunctivitis - Drug Profile ## Product Description ## Mechanism of Action ## R& D Progress ## Allergen for Birch Pollen Induced Allerg

  • Allergy Drug
  • Eye Disease
  • Ophthalmic Solution
  • OTC
  • Pharmaceutical